OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

27-Hydroxycholesterol stimulates cell proliferation and resistance to docetaxel-induced apoptosis in prostate epithelial cells
Shaneabbas Raza, Megan Meyer, Jared Schommer, et al.
Medical Oncology (2016) Vol. 33, Iss. 2
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

EMT Factors and Metabolic Pathways in Cancer
Ilias Georgakopoulos-Soares, Dionysios V. Chartoumpekis, Venetsana Kyriazopoulou, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 291

Cholesterol metabolism: New functions and therapeutic approaches in cancer
Huanji Xu, Sheng Zhou, Qiulin Tang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 1, pp. 188394-188394
Closed Access | Times Cited: 270

The Role of Oxysterols in Human Cancer
Alžběta Kloudová, F. Peter Guengerich, Pavel Souček
Trends in Endocrinology and Metabolism (2017) Vol. 28, Iss. 7, pp. 485-496
Open Access | Times Cited: 176

Even Cancer Cells Watch Their Cholesterol!
Romain Riscal, Nicolas Skuli, M. Celeste Simon
Molecular Cell (2019) Vol. 76, Iss. 2, pp. 220-231
Open Access | Times Cited: 161

Lipid Oxidation Derived Aldehydes and Oxysterols Between Health and Disease
Barbara Sottero, Gabriella Leonarduzzi, Gabriella Testa, et al.
European Journal of Lipid Science and Technology (2018) Vol. 121, Iss. 1
Closed Access | Times Cited: 115

CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer
Mahmoud A. Alfaqih, Erik R. Nelson, Wen Liu, et al.
Cancer Research (2017) Vol. 77, Iss. 7, pp. 1662-1673
Open Access | Times Cited: 100

LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies
Giovanna Revilla, Lídia Cedó, Mireia Tondo, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 134-157
Open Access | Times Cited: 52

Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism
Miriam Lee‐Rueckert, Marina Canyelles, Mireia Tondo, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 36-51
Open Access | Times Cited: 19

Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
Wen G. Jiang, Weilin Jin, Aman Xu
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2044-2071
Open Access | Times Cited: 8

The role of cholesterol oxidation products in food toxicity
Lisaura Maldonado‐Pereira, Matthew Daniel Schweiss, Carlo Barnaba, et al.
Food and Chemical Toxicology (2018) Vol. 118, pp. 908-939
Closed Access | Times Cited: 57

27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator
Sisi He, Erik R. Nelson
Maturitas (2017) Vol. 104, pp. 29-35
Open Access | Times Cited: 52

27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3
Zhaoxia Shen, Dongmei Zhu, Jiao Liu, et al.
Environmental Toxicology and Pharmacology (2017) Vol. 51, pp. 1-8
Closed Access | Times Cited: 51

27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer
Gurdeep Marwarha, Shaneabbas Raza, Kimberly Hammer, et al.
Chemistry and Physics of Lipids (2017) Vol. 207, pp. 108-126
Closed Access | Times Cited: 50

Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals
Zhun Wang, Shuanghe Peng, Hui Xie, et al.
Clinical and Experimental Medicine (2018) Vol. 18, Iss. 2, pp. 165-175
Closed Access | Times Cited: 47

Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
Angelika M. Starzer, Anna S. Berghoff, Rainer Hamacher, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e001458-e001458
Open Access | Times Cited: 33

The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells
Shaneabbas Raza, Megan Meyer, Casey Goodyear, et al.
Cancer Cell International (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 43

27-hydroxycholesterol decreases cell proliferation in colon cancer cell lines
Jessica A. Warns, Gurdeep Marwarha, Natalie Freking, et al.
Biochimie (2018) Vol. 153, pp. 171-180
Open Access | Times Cited: 39

MITOCHONDRIAL CHOLESTEROL AND CANCER
Carmen Garcı́a-Ruiz, Laura Conde de la Rosa, Vicent Ribas, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 76-85
Open Access | Times Cited: 36

Our evolving understanding of how 27-hydroxycholesterol influences cancer
Liqian Ma, Wonhwa Cho, Erik R. Nelson
Biochemical Pharmacology (2021) Vol. 196, pp. 114621-114621
Open Access | Times Cited: 32

27‐Hydroxycholesterol Drives the Spread of α‐Synuclein Pathology in Parkinson's Disease
Lijun Dai, Jiannan Wang, Xingyu Zhang, et al.
Movement Disorders (2023) Vol. 38, Iss. 11, pp. 2005-2018
Closed Access | Times Cited: 11

Status of programmed death-ligand 1 expression in sarcomas
Hyung Kyu Park, Mingi Kim, Minjung Sung, et al.
Journal of Translational Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 36

Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link
Arvand Asghari, Michihisa Umetani
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4822-4822
Open Access | Times Cited: 29

CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis
Zhijuan Liang, Yuanbin Chen, Liping Wang, et al.
Cell Cycle (2018) Vol. 18, Iss. 1, pp. 34-45
Open Access | Times Cited: 31

Revisiting prostate cancer metabolism: From metabolites to disease and therapy
Henrique J. Cardoso, Tiago M. A. Carvalho, Lara R. S. Fonseca, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1499-1538
Closed Access | Times Cited: 27

Oxysterols in cancer management: From therapy to biomarkers
Alžběta Spálenková, Petr Holý, Pavel Souček
British Journal of Pharmacology (2020) Vol. 178, Iss. 16, pp. 3235-3247
Open Access | Times Cited: 25

Page 1 - Next Page

Scroll to top